Opendata, web and dolomites
H2020 projects about "immunogenicity"
The page lists 35 projects related to the topic "immunogenicity".
| # | |||
|---|---|---|---|
| 1 | SO-CMA | Improving the safety of oral immunotherapy for cow's milk allergy in children | 2016 |
| 2 | SVNanoVax | Structural Vaccinology in the design of bionanoparticles with multi-copy antigen display for vaccines with enhanced efficacy | 2015 |
| 3 | NEWCARBOVAX | New generation of carbohydrate-based vaccines via rational understanding of their immunological mechanism | 2017 |
| 4 | GLYCOVAX | A training network for the rational design of the next generation of well-defined glycoconjugate vaccines | 2015 |
| 5 | EHVA | European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates | 2016 |
| 6 | TROJANANOHORSE | Hybrid immune-eluding nanocrystals as smart and active theranostic weapons against cancer | 2016 |
| 7 | ONCOINTRABODY | Targeting common oncogenes with intracellular monobodies | 2016 |
| 8 | PIGYVAX | Making a yeast-based candidate vaccine against Porcine Epidemic Diarrhea Virus (PEDV) | 2016 |
| 9 | NEW DEAL | New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinases | 2017 |
| 10 | Smart-4-Fabry | Smart multifunctional GLA-nanoformulation for Fabry disease | 2017 |
| 11 | SweetAim | Selective glycoimmuno-targeting for cancer therapy | 2016 |
| 12 | ZIKAVAX | Fast track development of a Zika vaccine based on measles vector | 2016 |
| 13 | OptiMalVax | Optimizing a deployable high efficacy malaria vaccine | 2017 |
| 14 | EBOVAC2 | Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861 | 2014 |
| 15 | EBOVAC1 | Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen – Sofia ref.: 115854 | 2014 |
| 16 | TANTUMorNEUVACCINE | Neutrophil subtypes: distinct cellular targets for therapeutic intervention | 2017 |
| 17 | PEVIA | PAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088 | 2017 |
| 18 | VSV-EBOPLUS | SYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE - Sofia ref.: 116068 | 2016 |
| 19 | ETVAX | ETVAX – the first oral vaccine for protection against traveller’s diarrhoea caused by ETEC | 2017 |
| 20 | APOSITE | Apoptotic foci: composition, structure and dynamics | 2019 |
| 21 | AllergyVAX | Next generation allergen immunotherapy based on specifically modified recombinant hypoallergens | 2018 |
| 22 | skILL | Intracellular signalling by modified lipopolysaccharide | 2019 |
| 23 | MINT | Multifunctional Immunocompatible NanoTheranostics to modulate tumor microenvironment and improve treatment monitoring: A double blow to pancreatic cancer | 2019 |
| 24 | CRUZIVAX | Vaccine for prevention and treatment of Trypanosoma cruzi infection | 2019 |
| 25 | SHIGETECVAX | Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea | 2019 |
| 26 | NeoCellBank | A revolutionary regenerative therapy for management of chronic inflammatory diseases based on neonatal Mesenchymal Stem Cells | 2019 |
| 27 | Vacc-iNTS | Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase 1 trial in Europe and sub-Saharan Africa | 2019 |
| 28 | VASA | Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa | 2019 |
| 29 | ImmuniPrDx | PrDx - Advanced Software for Predicting the Immune Response During Drug Development | 2019 |
| 30 | CandidaHunter | A Nanotechnology Based Blood Culture Medium to Detect Invasive Candida in Bloodstream | 2019 |
| 31 | INDIGO | Effective and Affordable Flu Vaccines for the World | 2020 |
| 32 | ENDFLU | Evaluation of ratioNally Designed Influenza vaccines | 2020 |
| 33 | NSC-Reconstruct | Novel Strategies for Cell-based Neural Reconstruction | 2020 |
| 34 | EDUC8 | Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity | 2020 |
| 35 | QS21-Mech | Target identification and elucidation of the molecular mechanism of action of saponin vaccine adjuvants QS-21 (QS21Mech) | 2020 |